House of Lords to question NHS England on life sciences industrial strategy

The House of Lords Science and Technology Committee will question NHS England on the life sciences and industrial strategy as a part of its ongoing inquiry tomorrow (Tuesday 13 March).

This evidence session will begin at 10.05 in the morning in Committee Room 4A of the House of Lords and will see the committee question Professor Tony Young, PhD, national clinical director, innovation, NHS England, about what action is needed to ensure the readiness of the NHS for the implementation of the life sciences industrial strategy as well as how it can better adopt innovative technology.

As reported on the government’s website questions that are likely to be asked include:

• Much of the evidence the committee have received says that the NHS is often poor at adopting new innovations. Why is this and what can be done to improve the situation?
• What are the challenges in implementing the Accelerated Access Review and the benefits of doing so? What happens if it is not implemented?
• The Life Sciences Strategy sets out ambitions for the use of patient data. Is the NHS ready for this level of innovation in patient data?

This session will be open to the public and can also be watched live on the internet.